drugset / Trial / NCT01976728

LutrePulse Hypogonadotropic Hypogonadism

NCT01976728

Phase 3 Completed 39 enrolled Ferring Pharmaceuticals
RandomizedParallel-groupDouble-blindTreatment

Summary

To compare the ovulation rate in women with primary amenorrhea with hypogonadotropic hypogonadism following pulsatile gonadotropin-releasing hormone (GnRH) treatment using the OmniPod pump versus placebo

Timeline

Start
2014-04-01
Primary completion
2018-02-23
Completion
2018-02-23

Drugs

EvaluationDrugModalityDoseRoute
Subject Gonadorelin Protein / enzyme biologic 10 ug Subcutaneous
Subject Gonadorelin Protein / enzyme biologic 15 ug Subcutaneous
Subject Gonadorelin Protein / enzyme biologic 20 ug Subcutaneous